• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Synthetic Blood Substitutes and Blood Products – A Market Briefing

$995.00 – $1,990.00

Clear
SKU: KLI1002540 Category: Diagnostics Market Research Pages: 70
  • Description
  • Table of Contents
  • Latest reports

Description

In addition to being one of the most important tissues in the body, blood has emerged as a key vector in the transmission of the world’s deadliest infectious diseases. With the rising demand for transfusions in a variety of conditions such as anemias, trauma, and high-blood-loss surgeries, supplies have been stretched and the dangers of disease transmission have added significant cost pressures to maintaining a safe supply.

One possible solution to ease the crunch, particularly in acute amergency care settings has been the development of synthetic blood substitutes and synthetic blood products. Blood products such as recombinant hemophilia factors and serum albumins are already on the market; oxygen carriers are only a few years away.

This briefing forecasts the market for synthetic blood products, including:

  • Hemoglobin based oxygen carriers (HBOCs)
  • Perflurocarbon based products (PFCs)
  • Recombinant factors for hemophilias, such as Factor VIII (TKT)
  • Synthetic platelets, and
  • Blood volume expanders, such as the albumins.

Blood demand is detailed by number of high-blood-loss procedures, acute vs chronic conditions, and geographic region, and total demand is forecasted to 2009. Market share and revenues of top products in the blood volume expander and recombinant factor markets are reported and estimated out to 2009. Oxygen transporting product revenues are forecasted to 2013, based on likely approvals and clinical acceptance trends.

In addition, product pipelines are analyzed from both technical aspects and clinical trials results, and profiles of 11 key players are provided.

Table of Contents

Chapter one: Executive Summary

  • Introduction
  • Blood Transfusion Demand and Supply
  • Synthetic Blood Products
  • Summary Market Forecast
  • Scope and Methodology

Chapter Two: Introduction: Blood, Associated Disorders, and Blood Products

  • Composition, Function and Formation

    • Red Blood Cells (Erythrocytes)
    • White Blood Cells (Leukocytes)
    • Platelets
    • Plasma
  • Blood Transfusions
  • Synthetic Blood Products: A Suitable Alternative
    • Blood Volume Expanders
    • Hemoglobin Based Oxygen Carriers
    • Perflurocarbon (PFC) Based Blood Products
    • Factor Products for Hemophilia A
    • Synthetic Platelets
    • Synthetic Blood Products Summary

Chapter Three: Novel Synthetic Blood Products in Clinical Trials

  • Hemolink (Hemosol)
  • Hemopure (Biopure)
  • Polyheme (Northfield Laboratories)
  • Oxygent (Alliance)
  • Oxycyte (Synthetic Blood International)
  • PHER-O2 (Sanguine)
  • Albrec (Mitsubishi Pharma)
  • Advate (Baxter)
  • Recombinant Factors
  • Synthocytes (Andaris)
  • Gene Therapy

Chapter Four: Worldwide Demand and Market Analysis

  • Blood Shortage Driving Demand for Alternatives
  • Blood Volume Expanders
  • Oxygen Carrier Market
  • Recombinant Factor Market

Chapter Five: Key Players and Their Technologies

  • Alliance Pharmaceuticals Inc.
  • Biopure Corp.
  • BioTime Inc.
  • Hemosol Corp.
  • JP Laboratories Inc.
  • Northfield Laboratories
  • Novo Nordisk A/S
  • Perftoran
  • Sanguine Corp.
  • Synthetic Blood International
  • Transkaryotic Therapies Inc.

List of Exhibits

  • Exhibit 1: Worldwide Demand for Red Blood Cells by Indication (Acute vs Chronic)
  • Exhibit 2: Summary of World Demand for RBCs 2003-2009
  • Exhibit 3: Number of High Blood Loss Surgical Procedures by Type
  • Exhibit 4: High Blood Loss Market: HBOC and PFC Agents 2007-2013
  • Exhibit 5: World Recombinant Factor Market Summary 2003-2009
  • Exhibit 6: World Market for Gene Therapy in Blood Disorders 2006-2011
  • Exhibit 7: Composition of Blood Plasma
  • Exhibit 8: Clinical Uses for Blood Substitutes
  • Exhibit 9: HBOCs Sources and Modification by Company
  • Exhibit 10: Recombinant Factor Products in Clinical Trials
  • Exhibit 11: Average Blood and Component Requirements by Condition
  • Exhibit 12: Annual Worldwide Demand for Red Blood Cells
  • Exhibit 13: Geographical Distribution of RBC Demand by Region (United States, Europe, Japan, ROW) 2003
  • Exhibit 14: Projected World Demand for RBCs 2003-2009
  • Exhibit 15: Number of High Blood Loss Surgical Procedures by Type (Number of Procedures, Units of RBCs per Procedure, Total Units Transfused, Market Value) 2003
  • Exhibit 16: Blood Volume Expanders Market by Brand 2002-2009
  • Exhibit 17: High Blood Loss Market HBOC and PFC Agent Revenues 2007-2013
  • Exhibit 18: World Recombinant Factor Market by Brand 2003-2009

 

    At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023
    June 6, 2023
    Clinical Laboratory Services Market, 8th Edition
    May 16, 2023
    COVID-19 Testing Markets, 2023
    April 24, 2023
    The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition
    April 13, 2023

Related products

  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

    $2,625.00 – $5,250.00
  • Placeholder image

    Synthetic Blood Substitutes and Blood Products – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • New Kalorama Report Pegs Clinical Lab Services Market at 168BN May 18, 2023
  • WHO Reports Lowered Threat Level of COVID-19; What Does it Mean for Testing? May 9, 2023
  • SDi Releases Flagship Market Research Report on Analytical and Life Science Instruments: The Global Assessment Report May 3, 2023
  • Despite Declines, COVID-19 Still a Large IVD Market May 1, 2023
  • Single Cell Genomics Market Reaches $1 Billion April 27, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Hispanics and Healthcare: Understanding Demographics, Health Statistics, and...The U.S Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medicat...
Scroll to top